Page 327 - Programme book for The International Liver Congress 2015, EASL ILC 2015

YI P1200 THE EFFECT OF AZATHIOPRINE ON THE RISK OF ePOSTERS
YI P1201 MALIGNANCY IN PATIENTS WITH PRIMARY SCLEROSING
YI P1202 CHOLANGITIS: A LONG-TERM MULTICENTER STUDY
YI P1203 Roman Zenouzi*, Tobias J. Weismüller, Kristin K. Jorgensen,
YI P1204 Henrike Lenzen, Peter Hübener, Kornelius Schulze, Michael Bubenheim,
YI P1205 Tom H. Karlsen, Kirsten M. Boberg, Michael P. Manns,
Ansgar W. Lohse, Christoph Schramm, Germany

LONG-TERM THERAPY WITH BEZAFIBRATE AND
URSODEOXYCHOLIC ACID IS INSUFFICIENT FOR
PREVENTING DISEASE PROGRESSION IN PATIENTS WITH
ADVANCED PRIMARY BILIARY CIRRHOSIS
Anna Reig*, Pilar Sesé, Albert Pares, Spain

DEFINITION AND COMPARATIVE ANALYSIS OF THE T CELL
RECEPTOR REPERTOIRE IN PATIENTS WITH PRIMARY
SCLEROSING CHOLANGITIS
Evaggelia Liaskou, Eva Kristine Klemsdal Henriksen*, Kristian Holm,
David Hamm, Janine Fear, Marte K. Viken, Johannes Roksund Hov,
Espen Melum, Harlan Robins, Johanna Olweus, Tom H. Karlsen,
Gideon M. Hirschfield, Norway

EFFECT OF IMMUNOSUPPRESSIVE DRUGS ON THE
KINETICS OF CO-INHIBITORY MOLECULE EXPRESSION
AND PRO-INFLAMMATORY CYTOKINE PRODUCTION BY
EFFECTOR T CELLS IN AUTOIMMUNE HEPATITIS
Charlotte R. Grant*, Rodrigo Liberal, Beth S. Holder, Giorgina Mieli-
Vergani, Diego Vergani, Serena Longhi, The United Kingdom

GENOMIC T CELL RECEPTOR SIGNATURES IN MATCHED
GUT, LIVER AND BLOOD SAMPLES FROM PRIMARY
SCLEROSING CHOLANGITIS PATIENTS
Eva Kristine Klemsdal Henriksen*, Kristin Kaasen Jørgensen,
Kristian Holm, Johanna Olweus, Kirsten Muri Boberg,
Gideon Hirschfield, Tom H. Karlsen, Evaggelia Liaskou, Norway

COMPREHENSIVE ANALYSES OF AUTOIMMUNE HEPATITIS
TYPE 1 ASSOCIATED MRNA, LNCRNA, AND MIRNA IN CD4+
T CELLS TARGETED BY PREDNISOLONE TREATMENT
Ryo Nakagawa*, Ryosuke Muroyama, Sayaka Ito, Keiko Takano,
Kaku Goto, Masahiro Nakano, Chisato Saeki,Yasuo Matsubara,
Naoya Kato, Mikio Zeniya, Japan

Vienna, Austria • April 22–26, 2015 327